Elekta Past Earnings Performance
Past criteria checks 2/6
Elekta's earnings have been declining at an average annual rate of -0.3%, while the Medical Equipment industry saw earnings growing at 3.9% annually. Revenues have been growing at an average rate of 5.9% per year. Elekta's return on equity is 10.6%, and it has net margins of 6.3%.
Key information
-0.3%
Earnings growth rate
-0.3%
EPS growth rate
| Medical Equipment Industry Growth | -9.5% |
| Revenue growth rate | 5.9% |
| Return on equity | 10.6% |
| Net Margin | 6.3% |
| Next Earnings Update | 27 Nov 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Elekta makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jul 24 | 18,116 | 1,134 | 3,067 | 1,444 |
| 30 Apr 24 | 18,119 | 1,302 | 3,011 | 1,394 |
| 31 Jan 24 | 18,221 | 1,433 | 3,058 | 1,350 |
| 31 Oct 23 | 18,021 | 1,344 | 3,050 | 1,330 |
| 31 Jul 23 | 17,370 | 1,121 | 3,041 | 1,368 |
| 30 Apr 23 | 16,869 | 943 | 3,001 | 1,369 |
| 31 Jan 23 | 15,984 | 813 | 2,818 | 1,394 |
| 31 Oct 22 | 15,249 | 826 | 2,803 | 1,419 |
| 31 Jul 22 | 14,866 | 1,087 | 2,646 | 1,368 |
| 30 Apr 22 | 14,548 | 1,154 | 2,528 | 1,372 |
| 31 Jan 22 | 13,976 | 1,079 | 2,444 | 1,384 |
| 31 Oct 21 | 13,955 | 1,172 | 2,334 | 1,424 |
| 31 Jul 21 | 13,791 | 1,165 | 2,268 | 1,491 |
| 30 Apr 21 | 13,763 | 1,254 | 2,229 | 1,486 |
| 31 Jan 21 | 14,104 | 1,321 | 2,254 | 1,536 |
| 31 Oct 20 | 14,179 | 1,307 | 2,340 | 1,573 |
| 31 Jul 20 | 14,354 | 1,153 | 2,453 | 1,612 |
| 30 Apr 20 | 14,601 | 1,084 | 2,537 | 1,657 |
| 31 Jan 20 | 14,680 | 1,212 | 2,540 | 1,679 |
| 31 Oct 19 | 14,343 | 1,115 | 2,476 | 1,663 |
| 31 Jul 19 | 13,964 | 1,179 | 2,381 | 1,658 |
| 30 Apr 19 | 13,555 | 1,198 | 2,335 | 1,592 |
| 31 Jan 19 | 12,877 | 1,164 | 2,278 | 1,409 |
| 31 Oct 18 | 12,315 | 1,295 | 2,230 | 1,273 |
| 31 Jul 18 | 11,888 | 1,315 | 2,198 | 1,144 |
| 30 Apr 18 | 11,573 | 1,348 | 2,157 | 1,095 |
| 31 Jan 18 | 11,879 | 939 | 2,125 | 1,147 |
| 31 Oct 17 | 11,795 | 639 | 2,129 | 1,144 |
| 31 Jul 17 | 11,326 | 389 | 2,150 | 1,083 |
| 30 Apr 17 | 10,704 | 125 | 2,093 | 1,018 |
| 31 Jan 17 | 10,596 | 108 | 2,139 | 977 |
| 31 Oct 16 | 10,470 | 70 | 2,200 | 991 |
| 31 Jul 16 | 10,864 | 203 | 2,238 | 1,044 |
| 30 Apr 16 | 11,221 | 137 | 2,362 | 1,065 |
| 31 Jan 16 | 11,469 | 402 | 2,548 | 1,070 |
| 31 Oct 15 | 11,474 | 548 | 2,526 | 1,022 |
| 31 Jul 15 | 11,213 | 558 | 2,485 | 974 |
| 30 Apr 15 | 10,839 | 552 | 2,383 | 952 |
| 31 Jan 15 | 10,938 | 1,029 | 2,097 | 904 |
| 31 Oct 14 | 10,771 | 1,026 | 2,027 | 902 |
| 31 Jul 14 | 10,647 | 1,017 | 1,999 | 896 |
| 30 Apr 14 | 10,694 | 1,148 | 1,974 | 866 |
| 31 Jan 14 | 10,471 | 1,173 | 1,964 | 805 |
Quality Earnings: EKTABS has high quality earnings.
Growing Profit Margin: EKTABS's current net profit margins (6.3%) are lower than last year (6.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EKTABS's earnings have declined by 0.3% per year over the past 5 years.
Accelerating Growth: EKTABS's earnings growth over the past year (1.2%) exceeds its 5-year average (-0.3% per year).
Earnings vs Industry: EKTABS earnings growth over the past year (1.2%) did not outperform the Medical Equipment industry 39.9%.
Return on Equity
High ROE: EKTABS's Return on Equity (10.6%) is considered low.